Viewing Study NCT05840445



Ignite Creation Date: 2024-05-06 @ 6:58 PM
Last Modification Date: 2024-10-26 @ 2:57 PM
Study NCT ID: NCT05840445
Status: COMPLETED
Last Update Posted: 2023-05-03
First Post: 2023-04-11

Brief Title: Efficacy of Prabotulinum and Onabotulinum Toxin-A for Facial Wrinkles
Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana
Organization: Instituto de Oftalmología Fundación Conde de Valenciana

Study Overview

Official Title: Efficacy of Prabotulinum Toxin-A and Onabotulinum Toxin-A for the Treatment of Expression Lines in the Upper Third of the Face
Status: COMPLETED
Status Verified Date: 2023-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The appearance of facial wrinkles lines or folds is a natural phenomenon during aging Different scales help classify wrinkles objectively such as the Facial Wrinkle Scale Others help classify patients subjective perspectives like the Face-Q questionnaire The application of Botulinum Toxin is the most performed non-surgical aesthetic procedure in the world to treat facial expression lines The present study aims to compare the efficacy of onabotulinum toxin-A BOTOX and prabotulinum toxin-A NABOTA to treat expression lines in the upper third of the face based on objective and subjective follow-up using the FWS scale and FACE-Q questionnaire respectively
Detailed Description: This is an experimental comparative longitudinal open-label prospective study at the Instituto de Oftalmología Fundación Conde de Valenciana IAP Mexico City Mexico

The investigators used a proportion formula to calculate the sample size with an alpha value of 005 and a precision of 3 The difference in the effect between the two toxins is 20 considering a 20 loss with a total of 18 patients A nonprobabilistic sampling of consecutive cases was performed Once patients were selected and included in the study they were randomly assigned to a group

After inclusion simple randomization was performed in the Onabotulinum and Prabotulinum groups Each group received intramuscular administration of onabotulinum toxin-A and prabotulinum toxin-A in the upper facial third

The investigators used descriptive statistics to analyze the demographic variables and employed the Mann-Whitney U test to assess differences in the quantitative and ordinal outcome variables between the groups before and at the end of the study Additionally the investigators employed the chi-square test to compare the intergroup results before and at the end of the study for nominal variables To compare intragroup results over time the investigators conducted a repeated measures ANOVA test for continuous variables Friedman test for ordinal variables and Cochrans Q test for nominal variables We used SPSS Version 20 Chicago IL USA for analysis and considered a value of p005 as statistically significant

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: None